Ausgabe 5/2016
Inhalt (10 Artikel)
Systematic Review
Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis
Hongmou Zhao, Hongliang Liu, Xiaojun Liang, Yi Li, Junhu Wang, Cheng Liu
Review Article
Advances in the Treatment of Non–small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
Konstantinos Leventakos, Aaron S. Mansfield
Review Article
Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
Shingo Nakayamada, Satoshi Kubo, Shigeru Iwata, Yoshiya Tanaka
Review Article
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
Vasileios S. Skouras, Charis Maragkos, Dimitra Grapsa, Konstantinos N. Syrigos
Open Access
Original Research Article
Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
Simon Gerber, Annette Gaida, Nicole Spiegl, Sandra Wymann, Adriano Marques Antunes, Ibrahim El Menyawi, Brigitte Zurbriggen, Alphonse Hubsch, Martin Imboden
Adis Drug Evaluation
BAY 81-8973 (Octocog Alfa; Kovaltry®): A Review in Haemophilia A
Gillian M. Keating
Adis Drug Evaluation
Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma
Karly P. Garnock-Jones
Adis Drug Evaluation
Infliximab Biosimilar (CT-P13; Infliximab-dyyb): A Review in Autoimmune Inflammatory Diseases
Hannah A. Blair, Emma D. Deeks
Erratum
Erratum to: Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases
Celeste B. Burness, Sean T. Duggan
Erratum
Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
Shingo Nakayamada, Satoshi Kubo, Shigeru Iwata, Yoshiya Tanaka